Folic acid and creatine as therapeutic approaches to lower blood arsenic: A randomized controlled trial

Environmental Health Perspectives

Volumn 123, Issue 12, 2015, Pages 1294-1301

  Peters, Brandilyn A ^a   Hall, Megan N ^a   Liu, Xinhua ^a   Parvez, Faruque ^a   Sanchez, Tiffany R ^a   van Geen, Alexander ^b   Mey, Jacob L ^b   Siddique, Abu B ^c   Shahriar, Hasan ^c   Uddin, Mohammad Nasir ^c   Islam, Tariqul ^c   Balac, Olgica ^a   Ilievski, Vesna ^a   Factor Litvak, Pam ^a   Graziano, Joseph H ^a   Gamble, Mary V ^a  

^a Columbia University ^*  (United States)

^b Department of Earth and Environmental Sciences   (United States)

^c Och Spine at New York Presbyterian Hospitals   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; CREATINE; CYANOCOBALAMIN; DRINKING WATER; FOLIC ACID; GUANIDINOACETIC ACID; HOMOCYSTEINE; PLACEBO; CREATININE; WATER POLLUTANT;

ADULT; ARSENIC POISONING; ARTICLE; BANGLADESH; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY REFERENCE INTAKE; DOWN REGULATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTENTION TO TREAT ANALYSIS; LONGITUDINAL STUDY; MALE; METHYLATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; URINALYSIS; AGED; BLOOD; DIETARY SUPPLEMENT; MIDDLE AGED; TOXICITY; URINE; WATER MANAGEMENT; WATER POLLUTANT;

ADULT; AGED; ARSENIC; BANGLADESH; CREATINE; CREATININE; DIETARY SUPPLEMENTS; DRINKING WATER; FEMALE; FOLIC ACID; HUMANS; MALE; METHYLATION; MIDDLE AGED; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION;

EID: 84949238553     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1409396     Document Type: Article

References (43)

1. Ahsan H, Chen Y, Kibriya MG, Slavkovich V, Parvez F, Jasmine F, et al. 2007. Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol Biomarkers Prev 16:1270-1278.
2. Ahsan H, Chen Y, Parvez F, Argos M, Hussain AI, Momotaj H, et al. 2006. Health Effects of Arsenic Longitudinal Study (HEALS): description of a multidisciplinary epidemiologic investigation. J Expo Sci Environ Epidemiol 16:191-205.
3. Basu A, Mitra S, Chung J, Guha Mazumder DN, Ghosh N, Kalman D, et al. 2011. Creatinine, diet, micronutrients, and arsenic methylation in West Bengal, India. Environ Health Perspect 119:1308-1313; doi:10.1289/ehp.1003393.
4. Benevenga NJ. 2007. Consideration of betaine and one-carbon sources of N5-methyltetrahydrofolate for use in homocystinuria and neural tube defects. Am J Clin Nutr 85:946-949.
5. Brosnan JT, da Silva RP, Brosnan ME. 2011. The metabolic burden of creatine synthesis. Amino Acids 40:1325-1331.
6. Carducci C, Birarelli M, Leuzzi V, Carducci C, Battini R, Cioni G, et al. 2002. Guanidinoacetate and creatine plus creatinine assessment in physiologic fluids: an effective diagnostic tool for the biochemical diagnosis of arginine:glycine amidinotransferase and guanidinoacetate methyltransferase deficiencies. Clin Chem 48:1772-1778.
7. Challenger F. 1945. Biological methylation. Chem Rev 36:315-361.
8. Drobna Z, Walton FS, Paul DS, Xing W, Thomas DJ, Styblo M. 2010. Metabolism of arsenic in human liver: the role of membrane transporters. Arch Toxicol 84:3-16.
9. Finkelstein JD, Kyle WE, Harris BJ, Martin JJ. 1982. Methionine metabolism in mammals: concentration of metabolites in rat tissues. J Nutr 112:1011-1018.
10. Gamble MV, Ahsan H, Liu X, Factor-Litvak P, Ilievski V, Slavkovich V, et al. 2005a. Folate and cobalamin deficiencies and hyperhomocysteinemia in Bangladesh. Am J Clin Nutr 81:1372-1377.
11. Gamble MV, Liu X. 2005. Urinary creatinine and arsenic metabolism [Letter]. Environ Health Perspect 113:A442.
12. Gamble MV, Liu X, Ahsan H, Pilsner R, Ilievski V, Slavkovich V, et al. 2005b. Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect 113:1683-1688; doi:10.1289/ehp.8084.
13. Gamble MV, Liu X, Ahsan H, Pilsner JR, Ilievski V, Slavkovich V, et al. 2006. Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr 84:1093-1101.
14. Gamble MV, Liu X, Slavkovich V, Pilsner JR, Ilievski V, Factor-Litvak P, et al. 2007. Folic acid supplementation lowers blood arsenic. Am J Clin Nutr 86:1202-1209.
15. Government of Bangladesh, United Nations. 2010. Towards an Arsenic Safe Environment in Bangladesh. Available: http://www.unicef.org/bangladeslVknowledgecentre_6194.htm [accessed 17 April 2015].
16. Guthmiller P, Van Pilsum JF, Boen JR, McGuire DM. 1994. Cloning and sequencing of rat kidney L-arginine:glycine amidinotransferase. Studies on the mechanism of regulation by growth hormone and creatine. J Biol Chem 269:17556-17560.
17. Hall M, Chen Y, Ahsan H, Slavkovich V, van Geen A, Parvez F, et al. 2006. Blood arsenic as a biomarker of arsenic exposure: results from a prospective study. Toxicology 225:225-233.
18. Hall MN, Liu X, Slavkovich V, Ilievski V, Pilsner JR, Alam S, et al. 2009. Folate, cobalamin, cysteine, homocysteine, and arsenic metabolism among children in Bangladesh. Environ Health Perspect 117:825-831; doi:10.1289/ehp.0800164.
19. Hu YC, Cheng HL, Hsieh BS, Huang LW, Huang TC, Chang KL. 2012. Arsenic trioxide affects bone remodeling by effects on osteoblast differentiation and function. Bone 50:1406-1415.
20. Hughes MF, Edwards BC, Herbin-Davis KM, Saunders J, Styblo M, Thomas DJ. 2010. Arsenic (+3 oxidation state) methyltransferase genotype affects steady-state distribution and clearance of arsenic in arsenate-treated mice. Toxicol Appl Pharmacol 249:217-223.
21. Institute of Medicine. 1998. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC:National Academies Press.
22. Kile ML, Hoffman E, Hsueh YM, Afroz S, Quamruzzaman Q, Rahman M, et al. 2009. Variability in biomarkers of arsenic exposure and metabolism in adults over time. Environ Health Perspect 117:455-460; doi:10.1289/ehp.11251.
23. Kinniburgh DG, Smedley PL. 2001. Arsenic Contamination of Groundwater in Bangladesh. Technical Report WC/00/19. Keyworth, UK:British Geological Survey.
24. Levey AS, Perrone RD, Madias NE. 1988. Serum creatinine and renal function. Annu Rev Med 39:465-490.
25. Lin S, Shi Q, Nix FB, Styblo M, Beck MA, Herbin-Davis KM, et al. 2002. A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol. J Biol Chem 277:10795-10803.
26. National Research Council. 2013. Critical Aspects of EPA’s IRIS Assessment of Inorganic Arsenic. Washington, DC:National Academies Press.
27. Nermell B, Lindberg AL, Rahman M, Berglund M, Persson LA, El Arifeen S, et al. 2008. Urinary arsenic concentration adjustment factors and malnutrition. Environ Res 106:212-218.
28. Nixon DE, Mussmann GV, Eckdahl SJ, Moyer TP. 1991. Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clin Chem 37:1575-1579.
29. Pfeiffer CM, Huff DL, Gunter EW. 1999. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 45:290-292.
30. Pilsner JR, Liu X, Ahsan H, Ilievski V, Slavkovich V, Levy D, et al. 2009. Folate deficiency, hyperhomo-cysteinemia, low urinary creatinine, and hypo-methylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ Health Perspect 117:254-260; doi:10.1289/ehp.11872.
31. R Core Team. 2014. R: A Language and Environment for Statistical Computing. Vienna, Austria:R Foundation for Statistical Computing. Available: http://www.R-project.org[accessed 30 June 2014].
32. Slot C. 1965. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 17:381-387.
33. Smith AH, Marshall G, Liaw J, Yuan Y, Ferreccio C, Steinmaus C. 2012. Mortality in young adults following in utero and childhood exposure to arsenic in drinking water. Environ Health Perspect 120:1527-1531; doi:10.1289/ehp.1104867.
34. Song X, Geng Z, Li X, Hu X, Bian N, Zhang X, et al. 2010. New insights into the mechanism of arsenite methylation with the recombinant human arsenic (+3) methyltransferase (hAS3MT). Biochimie 92:1397-1406.
35. Stead LM, Au KP, Jacobs RL, Brosnan ME, Brosnan JT. 2001. Methylation demand and homocysteine metabolism: effects of dietary provision of creatine and guanidinoacetate. Am J Physiol Endocrinol Metab 281:E1095-E1100.
36. Stead LM, Brosnan JT, Brosnan ME, Vance DE, Jacobs RL. 2006. Is it time to reevaluate methyl balance in humans? Am J Clin Nutr 83:5-10.
37. Steinmaus C, Yuan Y, Kalman D, Rey OA, Skibola CF, Dauphine D, et al. 2010. Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba, Argentina. Toxicol Appl Pharmacol 247:138-145.
38. van Geen A, Ahmed EB, Pitcher L, Mey JL, Ahsan H, Graziano JH, et al. 2014. Comparison of two blanket surveys of arsenic in tubewells conducted 12 years apart in a 25 km2 area of Bangladesh. Sci Total Environ 488-489:484-492.
39. van Geen A, Ahsan H, Horneman AH, Dhar RK, Zheng Y, Hussain I, et al. 2002. Promotion of well-switching to mitigate the current arsenic crisis in Bangladesh. Bull World Health Organ 80:732-737.
40. van Geen A, Cheng Z, Jia Q, Seddique AA, Rahman MW, Rahman MM, et al. 2007. Monitoring 51 community wells in Araihazar, Bangladesh, for up to 5 years: implications for arsenic mitigation. J Environ Sci Health A Tox Hazard Subst Environ Eng 42:1729-1740.
41. Wagner C, Briggs WT, Cook RJ. 1985. Inhibition of glycine N-methyltransferase activity by folate derivatives: implications for regulation of methyl group metabolism. Biochem Biophys Res Commun 127:746-752.
42. Wu CT, Lu TY, Chan DC, Tsai KS, Yang RS, Liu SH. 2014. Effects of arsenic on osteoblast differentiation in vitro and on bone mineral density and microstructure in rats. Environ Health Perspect 122:559-565; doi:10.1289/ehp.1307832.
43. Zimmerman S. 2011. Fifteen years of fortifying with folic acid: birth defects are reduced and healthcare expenses are averted. Sight Life Mag 25:54-59.